| pubmed-article:11246301 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11246301 | lifeskim:mentions | umls-concept:C0085393 | lld:lifeskim |
| pubmed-article:11246301 | lifeskim:mentions | umls-concept:C1527222 | lld:lifeskim |
| pubmed-article:11246301 | lifeskim:mentions | umls-concept:C0162645 | lld:lifeskim |
| pubmed-article:11246301 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11246301 | pubmed:dateCreated | 2001-3-14 | lld:pubmed |
| pubmed-article:11246301 | pubmed:abstractText | Fiberoptic bronchoscopy (FOB) and bronchoalveolar lavage (BAL) are major tools in the diagnosis of pulmonary complications in immunocompromised patients. Nevertheless, severe hypoxemia is an accepted contraindication to FOB in nonintubated patients. The purpose of this study was to evaluate the feasibility and safety of laryngeal mask airway (LMA)-supported FOB with BAL in immunosuppressed patients with suspected pneumonia and severe hypoxemia. | lld:pubmed |
| pubmed-article:11246301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11246301 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11246301 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11246301 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11246301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11246301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11246301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11246301 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11246301 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11246301 | pubmed:issn | 0090-3493 | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:VargasFF | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:PorterJJ | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:CardinaudJ... | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:FavierJ CJC | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:Gbikpi-Beniss... | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:HilbertGG | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:ValentinoRR | lld:pubmed |
| pubmed-article:11246301 | pubmed:author | pubmed-author:GrusonDD | lld:pubmed |
| pubmed-article:11246301 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11246301 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:11246301 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11246301 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11246301 | pubmed:pagination | 249-55 | lld:pubmed |
| pubmed-article:11246301 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:meshHeading | pubmed-meshheading:11246301... | lld:pubmed |
| pubmed-article:11246301 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11246301 | pubmed:articleTitle | Bronchoscopy with bronchoalveolar lavage via the laryngeal mask airway in high-risk hypoxemic immunosuppressed patients. | lld:pubmed |
| pubmed-article:11246301 | pubmed:affiliation | Medical Intensive Care Unit, Pellegrin Hospital, Bordeaux, France. | lld:pubmed |
| pubmed-article:11246301 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11246301 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11246301 | lld:pubmed |
